Back to Agenda
Session 1: Status on implementation of the CTR and how to keep momentum
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy, EFPIA, Belgium
Status on implementation of the CTR and how to keep momentum
Speaker(s)
Judith Creba, PHD
Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU, Novartis Pharma AG, Switzerland
Latest Status of the CTReg
Elke Stahl, PHD
Senior Expert, Clinical Trials Department, Federal Institute For Drugs and Medical Devices (BfArM), Germany
Panel Discussion with Q&A from Audience
Judith Creba, PHD
Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU, Novartis Pharma AG, Switzerland
Stéphanie Kromar
Senior Regulatory Affairs Manager, European Organisation for Research and Treatment of Cancer (EORTC) , Belgium
Sini Eskola, MPHARM, MS, MSC
Head of International Regulatory Policy and Innovation, Takeda, Belgium
Monique Al, PHD
Special advisor CCMO, Central Committee on Research Involving Human Subjects (CCMO), Netherlands
Have an account?